GARS1 and Charcot-Marie-Tooth disease: LysRS was chosen because, with GlyRS, it is the only other dual-localized synthetase functioning in both cytoplasm and mitochondria, while TyrRS was chosen because there is strong evidence that mutations in its encoding gene, YARS1, cause CMT (Wei et al., 2019).